AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2024

May 17, 2024

30071_dirs_2024-05-17_48ad8656-4fd7-47c4-afb1-6693869e0245.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-05-15

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-15	ResMed Common Stock	G	68200	—	Disposed	89204	Direct

Footnotes

F1: Represents a gift of shares to Bank of America, N.A. Successor Trustee of Peter C. Farrell Charitable Remainder Trust. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.